| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Horvath Mark W. | President, Breast & Skeletal | 250 CAMPUS DRIVE, MARLBOROUGH | /s/ Mark W. Irving, attorney-in-fact for Mr. Horvath | 06 Nov 2025 | 0002052858 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | HOLX | Common Stock | Award | +2,278 | +31% | 9,681 | 04 Nov 2025 | Direct | F1, F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | Represents performance stock units as to which the performance criteria has been satisfied but which remain subject to service-based vesting requirements. |
| F2 | Performance stock units are settled in shares of common stock on a one-for-one basis. |
| F3 | Includes 346 shares acquired pursuant to the Issuer's employee stock purchase plan since the date of the Reporting Person's most recently filed Form 4. |
| F4 | Includes 2,327 restricted stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan. |